Perkins Capital Management Inc Athersys, Inc Transaction History

Perkins Capital Management Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$0.18 - $0.86 $720 - $3,440	-4,000 Reduced 5.56%	68,000 $18,000
Q1 2022 Apr 20, 2022	BUY	$0.6 - $1.06 $7,800 - $13,780	13,000 Added 22.03%	72,000 $44,000
Q4 2021 Feb 10, 2022	BUY	$0.85 - $1.4 $30,175 - $49,700	35,500 Added 151.06%	59,000 $53,000
Q2 2021 Jul 28, 2021	BUY	$1.41 - $1.94 $9,165 - $12,610	6,500 Added 38.24%	23,500 $34,000
Q1 2021 Apr 28, 2021	BUY	$1.61 - $2.77 $5,635 - $9,695	3,500 Added 25.93%	17,000 $31,000
Q3 2020 Oct 28, 2020	SELL	$1.91 - $3.08 $955 - $1,540	-500 Reduced 3.57%	13,500 $26,000
Q1 2020 Apr 29, 2020	SELL	$1.17 - $3.0 $10,530 - $27,000	-9,000 Reduced 39.13%	14,000 $42,000
Q4 2019 Feb 03, 2020	BUY	$1.16 - $1.42 $10,440 - $12,780	9,000 Added 64.29%	23,000 $28,000
Q3 2019 Oct 23, 2019	BUY	$1.21 - $1.65 $16,940 - $23,100	14,000 New	14,000 $19,000
Q1 2019 Apr 22, 2019	SELL	$1.39 - $1.71 $20,850 - $25,650	-15,000 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$1.41 - $2.16 $8,460 - $12,960	-6,000 Reduced 28.57%	15,000 $22,000
Q3 2018 Oct 22, 2018	SELL	$1.86 - $2.18 $381,486 - $447,118	-205,100 Reduced 90.71%	21,000 $44,000
Q2 2018 Aug 02, 2018	BUY	$1.76 - $2.79 $36,476 - $57,822	20,725 Added 10.09%	226,100 $445,000
Q1 2018 Apr 23, 2018	SELL	$1.34 - $2.03 $211,720 - $320,739	-158,000 Reduced 43.48%	205,375 $376,000
Q4 2017 Jan 26, 2018	BUY	$1.65 - $2.45 $90,172 - $133,892	54,650 Added 17.7%	363,375 $658,000
Q3 2017 Oct 31, 2017	BUY	$1.5 - $2.55 $463,087 - $787,248	308,725	308,725 $636,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Perkins Capital Management Inc with notifications on news.